Innovative new vaccines and biologics facilities
Modular production facilities in France and Singapore are a ‘World First’.
About Modulus
Sanofi has inaugurated its two revolutionary new ‘Modulus’ production units. Modulus is a world first and will produce Sanofi’s next vaccines and biological drugs.
Located in France and Singapore, the next-generation Modulus facilities can manufacture multiple vaccines or biomedicines simultaneously.
Each Modulus facility:
34
Standardized mini-factories contained within.
Each Modulus facility:
4
Vaccines or biomedicines can be manufactured simultaneously.
Standardized design:
2
A single standardized design was implemented in two disparate international locations.
“PM Group were designers of the Modulus facilities from Concept through to Detailed Design. Their design was a result of true partnership and innovation collaboration with our clients, and the commitment of our team."
Aidan Hennessy
Project Manager
Innovative features
What is unique is that the Modulus facilities can be reconfigured in a matter of days or weeks to change technological platform. This compares to several months or longer in more conventional factories. Products will include attenuated viral vaccines, recombinant protein or messenger RNA vaccines. Modulus will also accommodate treatments derived from biotechnologies including enzymes or monoclonal antibodies.
With an investment of circa. $500m for each of the Modulus facilities, their innovation lies in the design, each housing the equivalent of 34 standardized mini-factories. These have interconnected equipment, modular according to the required technology. Production lines can be configured to meet current needs.
Related specialist
"The Modulus facilities world-class design was unique in that it was replicated across two international locations. Standard facility design is becoming more common and we are proud to have been key designers for these highly innovative projects," said Aidan.
Modulus is not just a new, more modern, ecological and connected factory.
It is a revolution in the way Sanofi will manufacture vaccines and biomedicines in the coming decades. Sanofi has reinvented everything to create a factory that will best meet the health challenges of patients around the world.
Aidan is pictured above with Leonard Sheil, PM Group, at the launch of the French Modulus facility in Neuville-sur-Saône, near Lyon.
Also above, an aerial view of the Singapore facility.
Contact Us
Thank you for your enquiry, we’ll be in touch.
In the meantime you may find this content relevant to your interests.
